Wall Street Lifts Targets on JCI and HCA

Analysts raised price targets on a broad range of names Tuesday, with building technology and healthcare leading the upgrades.

JCI drew the freshest activity. The consensus target on Johnson Controls International moved to $172.45 from $169.70. The stock carries 22 buy ratings and nine holds, giving it a constructive tilt as the company benefits from data-centre cooling demand.

HCA Healthcare saw its average target climb to $470.59 from $465.50. Two sells sit alongside nine holds and 16 buys, reflecting continued confidence in hospital volumes despite margin pressure.

Not all moves pointed higher. CSGP CoStar Group's consensus target slipped to $36.65 from $37.42 after a string of revisions. The real-estate data platform has struggled to convert its residential push into profits. HOOD Robinhood Markets also saw its average target trimmed, down to $132.90 from $134.90, with 26 buys still intact but sentiment edging cautious.

XYL Xylem saw multiple changes that pulled its average target down sharply, from $142.63 to $132.75, the biggest absolute drop in the batch. One analyst shifted to hold from buy.

META Platforms notched another target increase, to $848.38 from $846.79, with 54 buys on the stock. The move is modest but adds to a long run of upward revisions ahead of Thursday's earnings.

RCL Royal Caribbean's target ticked up to $351.73 from $351.69 as cruise demand holds firm into the year-end booking season.